CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Available-for-sale Securities
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Available-for-sale Securities of $0 as of 2017-12-30, per its 10-K filed 2018-02-13.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecurities · last filed 2018-02-13
- 2017-12-30: Available-for-sale Securities $0.00.
- 2016-12-31: Available-for-sale Securities $0.00.
- 2016-09-24: Available-for-sale Securities $0.00.
- 2016-06-25: Available-for-sale Securities $4.63M.
| Period end | Available-for-sale Securities |
|---|---|
| 2017-12-30 | $0.00 10-K · filed 2018-02-13 |
| 2016-12-31 | $0.00 10-K · filed 2018-02-13 |
| 2016-09-24 | $0.00 10-Q · filed 2016-11-02 |
| 2016-06-25 | $4.63M 10-Q · filed 2016-08-03 |
| 2016-03-26 | $4.55M 10-Q · filed 2016-05-04 |
| 2015-12-26 | $4.51M 10-K · filed 2017-02-14 |
| 2015-09-26 | $4.57M 10-Q · filed 2015-11-04 |
| 2015-06-27 | $4.56M 10-Q · filed 2015-07-30 |
| 2015-03-28 | $4.67M 10-Q · filed 2015-04-30 |
| 2014-06-28 | $11.86M 10-Q · filed 2014-08-07 |
| 2014-03-29 | $11.45M 10-Q · filed 2014-04-30 |
| 2013-12-28 | $11.16M 10-Q · filed 2014-08-07 |
| 2013-09-28 | $11.08M 10-Q · filed 2013-10-30 |
| 2012-12-29 | $6.78M 10-K · filed 2014-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |